
Simultaneously targets GLP-1, GIP, and glucagon receptors.
Studied for effects on hunger regulation and energy expenditure.
Higher concentration for extended and complex research designs.
Retatrutide is part of a new class of triple-agonist peptides currently being explored in metabolic research. Studies have examined its role in weight regulation, insulin signaling, and systemic energy balance.
Early findings suggest that combining GLP-1, GIP, and glucagon receptor activity may produce broader metabolic effects than single-pathway compounds. This includes potential impacts on caloric intake, fat metabolism, and overall metabolic efficiency.
As research evolves, Retatrutide continues to represent a shift toward multi-pathway metabolic investigation — particularly relevant when studying complex systems like female metabolism.
FemmeBioLabs prioritizes data-backed compounds and transparent positioning — no assumptions, no exaggerated claims.
500mg
NAD+ studied for cellular energy production and mitochondrial function.
$1,799.00
100 mg
GHK-Cu 100mg copper peptide for research on collagen synthesis, skin regeneration, and antioxidant activity. High purity. Laboratory use only.
$1,999.00